Clinical Trial Update: Effect of Bradykinin Receptor Antagonism on ACE Inhibitor-associated Angioedema [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether a bradykinin receptor antagonist reduces ACE inhibitor-associated angioedema was terminated; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ace Inhibitor-associated Angioedema

Drugs mentioned

• Bradykinin receptor antagonist

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: ACE Inhibitor-associated Angioedema | Phase 4 | Status: TERMINATED | Results posted: 2017-02-17